Free Trial
NYSE:ENFN

Enfusion Q4 2024 Earnings Report

Enfusion EPS Results

Actual EPS
$0.01
Consensus EPS
$0.03
Beat/Miss
Missed by -$0.02
One Year Ago EPS
N/A

Enfusion Revenue Results

Actual Revenue
$52.94 million
Expected Revenue
$53.98 million
Beat/Miss
Missed by -$1.04 million
YoY Revenue Growth
N/A

Enfusion Announcement Details

Quarter
Q4 2024
Time
After Market Closes
Conference Call Date
Monday, March 3, 2025
Conference Call Time
3:00PM ET

Enfusion Earnings Headlines

Clearwater Analytics reinstated with an Overweight at JPMorgan
Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why
Imagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA or Bitcoin, but by owning a simple index fund. It sounds impossible. Yet it happened – just a short time ago. Now a legendary figure says: "Brace yourselves. It's about to happen here, in America. But fair warning – it could be the worst thing that ever happens to you." This story has received little coverage in the press. But if history repeats, it could bump tens of millions of Americans into a 7-figure net worth practically overnight.tc pixel
Clearwater Analytics Finalizes Acquisition of Enfusion
See More Enfusion Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Enfusion? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Enfusion and other key companies, straight to your email.

About Enfusion

Enfusion (NYSE:ENFN) provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. It also offers Accounting/General Ledger System, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion Analytics System, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services. Enfusion, Inc. was founded in 1997 and is headquartered in Chicago, Illinois.

View Enfusion Profile

More Earnings Resources from MarketBeat